325 Capital’s Astrana Health ASTH Stock Holding History

325 Capital’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.9M	Sell	1,613,843 -225,233	-12%	-$8.11M	17.85%	1
2026 Q1	$45.1M	Hold	1,839,076	–	–	16.43%	2
2025 Q4	$45.6M	Buy	1,839,076 +645,123	+54%	+$17.1M	15.99%	2
2025 Q3	$33.8M	Buy	1,193,953 +307,037	+35%	+$8.32M	10.29%	4
2025 Q2	$22.1M	Hold	886,916	–	–	8.71%	6
2025 Q1	$27.5M	Hold	886,916	–	–	11.39%	3
2024 Q4	$28M	Buy	886,916 +206,009	+30%	+$9.78M	10.81%	4
2024 Q3	$39.5M	Buy	680,907 +59,562	+10%	+$2.93M	16.7%	1
2024 Q2	$25.2M	Buy	621,345 +28,535	+5%	+$1.13M	10.58%	4
2024 Q1	$24.9M	Hold	592,810	–	–	11.49%	4
2023 Q4	$22.7M	Hold	592,810	–	–	11.25%	4
2023 Q3	$18.3M	Buy	592,810 +103,157	+21%	+$3.56M	15.09%	4
2023 Q2	$15.5M	Buy	489,653 +132,246	+37%	+$4.53M	10.2%	5
2023 Q1	$13M	Hold	357,407	–	–	11.39%	4
2022 Q4	$10.6M	Hold	357,407	–	–	11.45%	6
2022 Q3	$13.9M	Buy	+357,407	New	+$16.4M	16.27%	3

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

325 Capital's ASTH Position: Q2 2026 in Review

325 Capital reduced its Astrana Health (ASTH) stake by 12% in Q2 2026, selling an estimated $8.11M and leaving 1,613,843 shares worth $74.9M. The position accounts for 17.85% of the portfolio, ranked #1.

325 Capital first reported a position in ASTH in Q3 2022 and has held it in 16 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

325 Capital held 1,613,843 shares of Astrana Health worth $74.9M as of Q2 2026.
325 Capital sold 225,233 Astrana Health shares in Q2 2026, an estimated $8.11M.
Astrana Health made up 17.85% of 325 Capital's portfolio in Q2 2026, its #1 holding.
325 Capital first reported a position in Astrana Health in Q3 2022 and has held it in 16 quarters since.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on 325 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.